Last reviewed · How we verify

Placebo for "Deficiency of Qi and Yin"

The University of Hong Kong · FDA-approved active Small molecule

Placebo for "Deficiency of Qi and Yin" is a Small molecule drug developed by The University of Hong Kong. It is currently FDA-approved for Control arm in clinical research for Deficiency of Qi and Yin (Traditional Chinese Medicine diagnosis).

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect. Used for Control arm in clinical research for Deficiency of Qi and Yin (Traditional Chinese Medicine diagnosis).

At a glance

Generic namePlacebo for "Deficiency of Qi and Yin"
SponsorThe University of Hong Kong
ModalitySmall molecule
Therapeutic areaTraditional Chinese Medicine / Comparative Effectiveness Research
PhaseFDA-approved

Mechanism of action

Placebos are inert substances used as controls in clinical trials. In this case, it is being studied as a control arm in research on Traditional Chinese Medicine (TCM) treatments for 'Deficiency of Qi and Yin,' a TCM diagnostic concept. Any observed clinical benefit would be attributable to patient expectation, natural disease course, or other non-pharmacological factors rather than direct molecular action.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo for "Deficiency of Qi and Yin"

What is Placebo for "Deficiency of Qi and Yin"?

Placebo for "Deficiency of Qi and Yin" is a Small molecule drug developed by The University of Hong Kong, indicated for Control arm in clinical research for Deficiency of Qi and Yin (Traditional Chinese Medicine diagnosis).

How does Placebo for "Deficiency of Qi and Yin" work?

A placebo has no active pharmacological mechanism and produces therapeutic effects solely through the placebo effect.

What is Placebo for "Deficiency of Qi and Yin" used for?

Placebo for "Deficiency of Qi and Yin" is indicated for Control arm in clinical research for Deficiency of Qi and Yin (Traditional Chinese Medicine diagnosis).

Who makes Placebo for "Deficiency of Qi and Yin"?

Placebo for "Deficiency of Qi and Yin" is developed and marketed by The University of Hong Kong (see full The University of Hong Kong pipeline at /company/the-university-of-hong-kong).

What development phase is Placebo for "Deficiency of Qi and Yin" in?

Placebo for "Deficiency of Qi and Yin" is FDA-approved (marketed).

Related